|
|
Other links at Articles > Business of Medicine |
| 1. |
Lilly Settles Zyprexa Case With Alaska for $15 Mln
|
|
|
Eli Lilly and Co on Wednesday said it agreed to pay $15 million to settle a lawsuit by the state of Alaska accusing it of concealing possible side effects from Zyprexa, its widely used schizophrenia medicine. Reuters Health Information
|
| 3. |
FDA Approvals: Rotarix and PegIntron/Rebetol
|
|
|
The FDA has approved an oral vaccine (Rotarix) and new recommendations for peginterferon alfa-2b (PegIntron) plus ribavirin (Rebetol) combination therapy. Medscape Medical News
|
|
|